FROM THE EDITOR


Diabetes testing guidelines deserve support from the lab community


D


By Linda Wilson Senior Editor


iabetes is one of the most common chronic diseases in the United States. In 2018, 34.2 million Americans, or 1 in 10,


had diabetes and 88 million American adults, or 1 in 3, had prediabetes, according to the Centers for Disease Control and Prevention (CDC). In addition, 7.3 million adults aged 18 years or older who met laboratory criteria for diabetes were not even aware that they had the disease. Diabetes also is a major contributor to the


nation’s annual healthcare tab. In a 2018 report, the American Diabetes Association (ADA) said the total estimated 2017 direct medical costs from diagnosed cases of diabetes was $237 billion. On an individual level, each person diagnosed with diabetes incurs average medical expen-


ditures of $16,752 per year, of which about $9,601 is directly attributable to diabetes, the ADA said, adding that this per-person cost is about 2.3 times higher than it is for people without a diabetes diagnosis. None of this is news to clinical laboratorians. Testing to diagnose new cases of diabetes and prediabetes or to monitor blood sugar control in existing cases of diabetes is an important part of the daily workflow at many clinical labs. What may be news to laboratorians, however, is an ongoing effort on the part of the ADA and the American Association for Clinical Chemistry (AACC) to update diabetes testing guidelines. The guidelines were first crafted in 2002 and revised in 2011. The nine-member expert committee has been working on reviewing new medical evidence and writing revisions for several years. The committee members released a preliminary draft of the guidelines at the AACC’s annual meeting in September. Medical Laboratory Observer describes some of those recommendations and the overall guideline-review process in an article in this issue. As you know, standardization of diagnostic methods and measures ensures that a patient will get the same result no matter what lab performs the testing. In fact, the idea of standardization that is based on medical evidence is a central tenant of the healthcare industry’s efforts to improve the quality of patient care. Committee members have put in many volunteer hours so far: about a month of 40-hour work weeks, according to the estimate of one committee member. It is important work, and I am glad that this group has agreed to undertake this endeavor. Committee Chairperson David Sacks MB, ChB, FRCPath, Adjunct Professor


of Medicine, Georgetown University; Clinical Professor of Pathology, George Washington University, told me he cannot predict when the preliminary guidelines will be in final form. The COVID-19 pandemic has slowed forward momentum in this project — just as it has for so many others. I urge all of you to learn about the preliminary guidelines. You will have an opportunity to submit comments at some point in the process. And once the recommendations become final, you should evaluate them and consider what, if any, procedures you should update in your lab’s daily work to align with the recommendations. I welcome your comments, questions, and opinions – please send them to me at lwilson@mlo-online.com.


4 DECEMBER 2021 MLO-ONLINE.COM MEDICAL LABORATORY OBSERVER Vol.53, No.12


Group Publisher/Executive Editor Kristine Russell


krussell@mlo-online.com


Senior Editor Linda Wilson


lwilson@mlo-online.com


Graphic Artist Patti Connors pconnors@endeavorb2b.com


Audience Development/List Rentals Laura Moulton lmoulton@endeavorb2b.com


Ad Traffic Coordinator: Ray Porter rporter@endeavorb2b.com


eProduct Coordinator Mary Haberstroh mhaberstroh@endeavorb2b.com


ADVERTISING


East Coast/Midwest Sales (except IL) Classified/Recruitment Advertising Carol Vovcsko (941) 321-2873 cvovcsko@mlo-online.com


South/West Coast/Illinois Sales Lora Harrell (941) 328-3707 lharrell@mlo-online.com


MLO EDITORIAL ADVISORY BOARD


John Brunstein, PhD, Biochemistry (Molecular Virology) President & CSO PathoID, Inc., British Columbia, Canada


John A. Gerlach, PhD, D(ABHI) Laboratory Director Michigan State University, East Lansing, MI


Barbara Strain, MA, SM(ASCP), CVAHP Principal, Barbara Strain Consulting LLC Formerly Director, Value Management University of Virginia Health System, Charlottesville, VA


Jeffrey D. Klausner, MD, MPH Professor of Preventive Medicine in the Division of Dis- ease Prevention, Policy and Global Health, Department of Preventive Medicine at University of Southern California Keck School of Medicine.


Susan McQuiston, JD, MT(ASCP), SCy(ASCP) Instructor, Biomedical Laboratory Diagnostics Program Michigan State University, East Lansing, MI


Donna Beasley, DLM(ASCP) Director


Huron Healthcare, Chicago, IL


Anthony Kurec, MS, H(ASCP)DLM Clinical Associate Professor, Emeritus SUNY Upstate Medical University, Syracuse, NY


Suzanne Butch, MLS(ASCP)CM , SBBCM Freelance Consultant, Ann Arbor, MI


Paul R. Eden, Jr., MT(ASCP), PhD Lt. Col., USAF (ret.) (formerly) Chief, Laboratory Services 88th Diagnostics/Therapeutics Squadron Wright-Patterson AFB, OH Daniel J. Scungio, MT (ASCP), SLS, CQA (ASQ) Consultant at Dan the Lab Safety Man and Safety Officer at Sentara Healthcare, Norfolk, VA


CORPORATE TEAM , DLMCM


CEO Chris Ferrell CFO William Nurthen CRO/CMO June Griffin


Chief Administrative and Legal Officer Tracy Kane COO Patrick Rains


EVP Special Projects Kristine Russell


2477 Stickney Point Rd., Suite 221B Sarasota, FL 34231 Phone: (941) 388-7050 Fax: (941) 388-7490 www.mlo-online.com


MLO - MEDICAL LABORATORY OBSERVER


(ISSN: 0580-7247). Published monthly, with an additional issue in NOVEMBER, by Endeavor Business Media, LLC., 2477 Stickney Point Rd, Suite 221B, Sarasota, FL 34231 (941) 388-7050. Subscription rates: $127.60/ year in the U.S.; $154.88 Canada/Mexico; Intl. subscriptions are $221.43/year. All issues of MLO are available on microfilm from University Microfilms International, Box 78, 300 N. Zeeb Rd., Ann Arbor, MI 48106. Current single copies (if available) $15.00 each (U.S); and $20.00 each (Intl.). Back issues (if available) $17.60 each (U.S.); $22.00 each (Intl.). Payment must be made in U.S. funds on a U.S. bank/ branch within the continental U.S. and accompany request. Subscription inquiries: subscriptions@endeavorb2b.com. MLO is indexed in the Cumulative Index for Nursing and Allied Health Literature and Lexis-Nexis. MLO Cover/CE, Clinical Issues, and Lab Management features are peer reviewed. Title®


registered U.S. Patent Office. Copyright© 2021 by Endeavor


Business Media, LLC. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage-and- retrieval system, without written permission from the publisher. Office of publication: Periodicals Postage Paid at Nashville, TN 37209 and at additional mailing offices. Postmaster: Send address changes to Omeda (MLO Medical Laboratoy Observer), PO Box 3257, Northbrook, IL 60065-3257.


Printed in U.S.A.

Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54